Congenital triangular alopecia (CTA), also known as temporal triangular alopecia; originally described by Sabouraud in 1905; is a type of triangular, unilateral, nonprogressive, noncicatricial type of alopecia affecting mostly the temporal region of the scalp. It usually presents at birth or in early childhood, however adult cases have also been reported. Routinely confused with alopecia areata; dermoscopy helps in the diagnosis of this condition. We report a case of CTA with clinical and dermoscopic findings and discuss the differential diagnosis.
Introduction
Congenital triangular alopecia (CTA), also known as temporal triangular alopecia (TTA) or Brauer nevus, is a type of circumscribed, nonprogressive, noncicatricial type of alopecia, which was originally described by Sabouraud in 1905 as "alopecia triangulaire congenitale de la temp." [1] We report a case of CTA manifesting since birth along with its clinical and dermoscopic differentials.
Case Report
A 16-year-old male presented with a localized patch of hair loss over the frontotemporal region since birth. There was no history of any trauma during birth or any absence of skin. There was no history of consanguinity or any other family members affected by the same disorder. On clinical examination, triangular patch of alopecia measuring approximately 5 cm × 4 cm was present over the frontotemporal region of the scalp with base of the triangle in the front and apex toward the vertex [ Figure 1 ]. Dermoscopy (×50) showed vellus hairs in the bald patch along with normal terminal hairs surrounding the patch. The hair follicular openings were intact, and empty follicles were present [ Figure 2 Rest of the scalp hair, body hair, nails, and mucosae were normal. Systemic examination was normal. On histopathology, epidermis was normal. There was presence of vellus hairs along with miniaturization of hair follicles. There was absence of any inflammatory infiltrate [ Figure 4 ]. Rest of the skin adnexa were normal. Prognosis was discussed with the parents of the patient and follicular unit extraction was suggested.
Discussion
CTA; also known as TTA, is a type of circumscribed, nonprogressive, noninflammatory, noncicatricial type of alopecia. It remains stable throughout the life. It has an incidence of 0.11%. [2] There is no sex predominance. Even though the name states congenital, many of the cases manifest in pediatric age group, whereas in our case the symptoms were present since birth. There are also reports of the disease manifesting in adulthood. [3] It can present as triangular, oval, or lancet-shaped patch of alopecia. [4] Yin Li and Yesudian reported up to 79% cases presenting with unilateral involvement whereas the remaining showed bilateral involvement. Unilateral involvement was seen in our case. [5] As the name suggests, temporal region of the scalp is the most common area affected; followed by frontotemporal and then the occipital in 2.5% cases. [6, 7] Multiple pathomechanisms have been postulated to explain the nature of the disease; such as phylogenetic and embryological relation. Mosaicism is another proposed mechanism, and it is inherited as a para-dominant trait associated with postzygotic loss of the wild-type allele in a heterozygote state. [6] This can explain the pathogenesis in congenital variant of CTA; but not in acquired type. Acquired type of CTA arises from miniaturization of hair follicles; which ultimately forms the vellus hairs; characteristic of the disease.
Down's syndrome, iris-nevus syndrome, phakomatosis pigmentovascularis, aplasia cutis, congenital heart disease, and bone and tooth abnormalities may be associated with CTA. [8] Differential diagnosis to be considered include alopecia areata, androgenetic alopecia (AGA), aplasia cutis, tinea capitis, and trichotillomania.
As alopecia areata remains the closest differential in this case, dermoscopy aids in the diagnosis of this rare entity and prevents the undue use of topical and intra lesional steroids. Dermoscopic features of CTA are intact follicular openings, empty follicles, presence of vellus hairs in the bald patch and presence of terminal hairs surrounding the patch.
Black dots, yellow dots, broken hairs, cadaverised hairs or exclamation mark hairs which are typical of alopecia areata are not seen in this disorder. [9] Bilateral frontotemporal recession of the hairline differentiates CTA from AGA. Potassium hydroxide examination will help in differentiating between CTA and tinea capitis. Typical tonsure pattern of alopecia and perifollicular hemorrhage and pigmentation in dermoscopy, helps it to differentiate from trichotillomania.
No history of any trauma or absence of skin over the scalp since birth; rules out aplasia cutis. On histopathology, epidermis and dermis are unremarkable with no inflammatory infiltrate. There is normal number of follicles, presence of vellus hairs and miniaturization of the hair follicle. Rest of the skin adnexa such as sebaceous glands, sweat glands, collagen bundles, and vessels are normal. Inui et al. have proposed a criteria to diagnose CTA. [9] 1. Triangular or lancet-shaped patch of alopecia involving frontotemporal scalp 2. Trichoscopically normal follicular openings with vellus hairs surrounded by normal terminal hair area 3. Trichoscopically no broken hairs, tapering hairs, black dots, yellow dots and orifice loss, and 4. Persistent without significant hair regrowth for 6 months after clinically or trichoscopically confirming the existence of vellus hairs.
There is no effective treatment modality for CTA, and the patient should be counseled regarding the benign nature of the disease. There are very few reports regarding use of topical minoxidil in the treatment of CTA. [10] Surgical excision is possible only in selected cases of small and localized patch of alopecia. Hair transplant can be an option for patients with psychological upset. This case was reported to diagnose such rare entity which can be easily mistaken for alopecia areata and undue use of topical and intralesional steroids can be avoided.
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